These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25026844)

  • 1. [Hepatitis C. An increase in interferon-free therapy].
    Warpakowski A
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():8. PubMed ID: 25026844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti HCV drugs--ribavirin, telaprevir].
    Sakamoto M; Enomoto N
    Nihon Rinsho; 2012 Apr; 70(4):614-9. PubMed ID: 22568142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs for hepatitis C.
    Flisiak R; Parfieniuk A
    Expert Opin Investig Drugs; 2010 Jan; 19(1):63-75. PubMed ID: 20001555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and the 'cure'.
    Cooksley WG
    Aust Fam Physician; 1998 Dec; 27(12):1086. PubMed ID: 9919728
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternative interferons and immunomodulators in the treatment of hepatitis C.
    Alao H; Jake Liang T
    Liver Int; 2014 Feb; 34 Suppl 1():133-8. PubMed ID: 24373090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daclatasvir (Daklinza) for HCV genotype 3 infection.
    Med Lett Drugs Ther; 2015 Oct; 57(1479):142-3. PubMed ID: 26445205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in the treatment of interferon-resistant hepatitis C].
    Kumada M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1759-62. PubMed ID: 10581760
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral resistance and the future landscape of hepatitis C virus infection therapy.
    Wyles DL
    J Infect Dis; 2013 Mar; 207 Suppl 1():S33-9. PubMed ID: 23390303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment duration for genotypes 2 and 3: still confusing after all these years.
    Jensen DM
    J Clin Gastroenterol; 2010 Sep; 44(8):527-8. PubMed ID: 20628314
    [No Abstract]   [Full Text] [Related]  

  • 11. Adding telaprevir improves cure rate in patient with HCV infection.
    AIDS Patient Care STDS; 2010 Dec; 24(12):807. PubMed ID: 21188771
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral kinetics in hepatitis C.
    Lutchman G; Hoofnagle JH
    Hepatology; 2003 Jun; 37(6):1257-9. PubMed ID: 12774002
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and management of hepatitis C virus-infected children.
    Jhaveri R
    Pediatr Infect Dis J; 2011 Nov; 30(11):983-5. PubMed ID: 21997662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will interferon-free regimens prevail?
    Welsch C; Zeuzem S
    Gastroenterology; 2012 May; 142(6):1351-5. PubMed ID: 22537442
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
    Xirouchakis E; Triantos C; Manousou P; Sigalas A; Calvaruso V; Corbani A; Leandro G; Patch D; Burroughs A
    J Viral Hepat; 2008 Oct; 15(10):699-709. PubMed ID: 18673428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 18. [When and how should hepatitis C be treated?].
    Färkkilä M
    Duodecim; 2010; 126(1):41-8. PubMed ID: 20405608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.
    Singal AG; Waljee AK; Shiffman M; Bacon BR; Schoenfeld PS
    Aliment Pharmacol Ther; 2010 Oct; 32(8):969-83. PubMed ID: 20937042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic strategies for hepatitis C].
    Tsubota A; Kumada H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):441-7. PubMed ID: 15359839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.